HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intense immunosuppression for the treatment of an immune reconstitution inflammatory syndrome-like exacerbation after natalizumab withdrawal: a case report.

AuthorsMaria Sepúlveda, Sara Llufriu, Yolanda Blanco, Nuria Solà-Valls, Delon La Puma, Joan Berenguer, Pablo Villoslada, Albert Saiz
JournalJournal of neurology (J Neurol) Vol. 262 Issue 1 Pg. 219-21 (Jan 2015) ISSN: 1432-1459 [Electronic] Germany
PMID25408366 (Publication Type: Case Reports, Letter)
Chemical References
  • Immunologic Factors
  • Immunosuppressive Agents
  • Natalizumab
  • Rituximab
  • Cyclophosphamide
Topics
  • Adult
  • Cyclophosphamide (administration & dosage, pharmacology)
  • Female
  • Humans
  • Immune Reconstitution Inflammatory Syndrome (drug therapy, etiology)
  • Immunologic Factors (administration & dosage)
  • Immunosuppression Therapy (methods)
  • Immunosuppressive Agents (administration & dosage)
  • Multiple Sclerosis, Relapsing-Remitting (drug therapy, physiopathology)
  • Natalizumab (administration & dosage)
  • Rituximab (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: